Integrated Safety Update of Abrocitinib in 3802 Patients With Moderate-to-Severe Atopic Dermatitis: Data From More Than 5200 Patient-Years With Up to 4 Years of Exposure
media
posted on 2024-06-16, 23:36 authored by Adis Journals on behalf of:, Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, Kanti Chittuluru<div><strong>Article full text</strong></div>
<p>The above features represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2024</p>
History
Related Materials
- 1.
- 2.
